human fibroblast-derived dermal substitute

Clinical Research Poster

A Multicenter, Randomized, Single-blind Trial Comparing the Efficacy of Viable Cryopreserved Placental Membrane to Human Fibroblast-derived Dermal Substitute for the Treatment of Chronic Diabetic Foot Ulcers

10/16/2018

BACKGROUND: Randomized, controlled clinical trials (RCTs), the gold standard to determine treatment efficacy against a control, have demonstrated advantages of skin substitutes for the treatment of chronic diabetic foot ulcers (DFUs) in...

BACKGROUND: Randomized,...

10/16/2018

Wounds

Case Report

Treatment of Chronic Leg Ulcers with a Human Fibroblast-Derived Dermal Substitute: A Case Series of 114 Patients

03/10/2004

A. Vaalasti ;

A. Hjerppe ;

Leslie Turner , MD;

M. Hjerppe ;

R. Raudasoja ;

V. Autio ;

03/10/2004

Wounds

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

human fibroblast-derived dermal substitute

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products